Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

31.02
Delayed Data
As of Feb 17
 +0.13 / +0.42%
Today’s Change
21.11
Today|||52-Week Range
34.06
+0.65%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close30.89
Today’s open30.92
Day’s range30.53 - 31.15
Volume281,596
Average volume (3 months)232,835
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+55.95%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio155.1
Price/Sales11.37
Price/Book8.33

Competitors

 Today’s
change
Today’s
% change
LOXOLoxo Oncology Inc+0.36+0.87%
IPXLImpax Laboratories I...0.000.00%
DEPODepomed Inc-0.38-2.26%
SGYPSynergy Pharmaceutic...+0.01+0.17%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)$0.07
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs